It remains unknown whether application of nasal high flow (NHF) is effective after liberation from non-invasive ventilation (NIV). This study was aimed at investigating the effect of NHF in patients ready for weaning from NIV.
Introduction
Non-invasive ventilation (NIV) has been recognized as effective therapy in improving gas exchange while reducing dyspnea in patients with not only hypercapnic but also hypoxemic respiratory failure. (1, 2) Previous studies have shown that NIV can treat respiratory failure without invasive mechanical ventilation, (3) avert the need for re-intubation after 11(1): extubation in patients with risk factors, (4) and facilitate weaning from invasive ventilator support in medical patients predominantly with chronic obstructive pulmonary disease (COPD). (5) Contrary to these beneficial effects of NIV, there are some concerns regarding difficulties of NIV management. NIV prevents early mobilization, causes gastric distension, inhibits communication and oral intake, is poorly tolerated in some patients, and associated with facial injuries especially when the duration of NIV management is prolonged. (6) Thus, liberation from NIV as early as possible is one of the major goals in managing respiratory failure under NIV application. However, some patients develop respiratory failure after weaning from NIV to oxygen face mask even though the final positive end expiratory pressure (PEEP) level is at a minimum, which suggest that bridging therapy from NIV to face mask might be necessary for some patients.
Nasal high flow (NHF) oxygen therapy, which is well established in neonates and has recently been used in adult populations, (7) can deliver high flow humidified, blended air and oxygen up to 60 L/min via widebore nasal cannula at a prescribed fraction of inspiratory oxygen (FIO 2 ). (8) Given that the beneficial effects of NHF, such as improving oxygenation, reducing work of breathing, and facilitating secretion clearance, have been reported in recent studies, (9-11) NHF might be useful to wean patients from NIV to oxygen face mask efficiently and safely. However, there are few studies which have examined the effects of NHF on respiratory parameters through comparison with those of NIV, and evaluated the efficacy of NHF after liberation from NIV.
In this study, we examined the effect of NHF application after liberation from NIV management, compared with the historical control group in which patients received oxygen face mask after weaning from NIV.
Materials and Methods
This prospective, observational study was conducted in our 8-bed intensive care unit (ICU) of Kawasaki Municipal Hospital in Japan to 11(1): investigate the effect of NHF on respiratory parameters in patients weaned from NIV during the period from September 2012 to March 2013. The protocol was approved by the regional ethics committee, which waived informed consent, since this study was observational in nature, and all procedures were established as routine practices in our ICU.
Patients receiving NIV through full face mask for more than 24 hours due to hypoxemic respiratory failure were screened for eligibility in this study, and all patients who met all the following inclusion criteria were enrolled in this study: (1) partial pressure of arterial oxygen (PaO 2 ) to more than 200 mmHg; (2) RR less than 30 bpm; (3) pH of blood gas analysis more than 7.35; (4) hemodynamic stability without vasopressor therapy; (5) adequate conscious level and cough reflex; (6) no agitation.
The setting of NHF was not changed until 1hour after the initiation of NHF therapy if patients could maintain oxygen saturation by pulse oximetry (SpO 2 ) more than 92% and a RR less than 35 bpm. The setting of NHF was adjusted by the attending physician 1 hour after the initiation of NHF therapy to achieve SpO 2 more than 93% and respiratory rate less than 30 bpm. Patients were weaned from NHF therapy by reducing gas flow rate gradually. NHF therapy was considered successful if the patients were weaned from NHF therapy without respiratory failure as defined below, rescue NIV therapy, and intubation for 24 hours.
In the historical control group, the weaning from NIV was performed in the same way as the NHF therapy group. They received standard face mask oxygen therapy (flow 30 l/min and FIO 2 equal to or less than 0. partial pressure of arterial carbon dioxide (PaCO 2 ) > 50 mm Hg]; (4) clinical signs of respiratory muscle fatigue such as use of accessory muscle and paradoxical motion of the abdomen; (5) inability to remove secretions; (6) severe dyspnea. In case of respiratory failure persisting for more than 4 hours without improvement after NIV application, patients were to be strongly considered for intubation.
Demographic data, diagnosis, sequential organ failure assessment (SOFA) score at ICU admission, and duration of NIV were recorded at the enrollment of the study. Blood pressure, heart rate, RR and SpO 2 were monitored continuously. Blood gases were analyzed every morning at 7 am, just before the interruption of NIV, 1hour after the initiation of NHF therapy, and at any time if indicated. In the historical control group, the last blood gas analysis data before liberation from NIV and the first data after oxygen mask therapy were extracted from medical records. Duration of NHF therapy, the rate of rescue NIV therapy and intubation, the frequency of respiratory failure, and the length of ICU stay after the first liberation from NIV were also recorded. Furthermore, each patient was asked which device was more comfortable, NIV with full face mask or NHF with a wide-bore nasal cannula, after completion of the study in the NHF group.
Primary end point was the change of respiratory parameters, including P/F ratio and RR, 1 hour after initiation of NHF or oxygen mask compared with those during NIV. Secondary end points were the rate of rescue NIV therapy and intubation, the frequency of respiratory failure, the duration of NHF therapy, the length of ICU stay after weaning from NIV, and acceptability of NHF therapy compared with NIV.
Results were presented as mean ±SD for variables with a normal distribution, or medians and interquartile range for variables with a nonnormal distribution, and compared with Student's t test or MannWhitney U test as appropriate. Categorical variables were compared with Fisher's exact test. A p-value less than 0.05 was considered as statistically significant.
Results
All patients under NIV management, who were ready for weaning, were screened for eligibility over the study period. Nine patients, who passed the inclusion criteria, participated in the study overall. Clinical characteristics and demographic data at admission to ICU are summarized in table1. Duration of NIV ranged from 2 to 6 days. All nine patients received NHF therapy immediately after interruption of NIV, and the respiratory setting was not changed until the first blood sampling, 1 hour after initiation of NHF in all patients.
In the historical control group, who received oxygen mask therapy after interruption of NIV management, P/F ratio decreased significantly compared with that just before liberation from NIV therapy (194.3 ± 20.1 versus 255.9 ± 58.1 mmHg, p=0.013; table 2). On the other hand, P/F ratio did not change significantly in nine patients who received NHF therapy immediately after weaning from NIV as shown in table 2 (231 ± 43.6 versus 250.7 ± 34.2 mmHg, p=0.367). Respiratory rate after initiation of NHF or oxygen mask was also comparable with that during
NIV (table 2).
Although two of eight patients in the historical control group required rescue NIV therapy again due to development of respiratory failure, of whom one patient was intubated after all, no patient developed respiratory failure or received NIV rescue therapy after initiation of NHF therapy in the NHF group. However, there was no significant difference between both groups regarding the rate of rescue NIV therapy (p=0.206). The duration of NHF therapy was 2 (1 to 3.25) days, and the length of ICU stay after liberation from NIV in the NHF group was not different significantly from that of the historical control group {4 (3 to Our study demonstrated that NHF therapy after weaning from NIV is effective in maintaining sufficient oxygenation compared with oxygen face mask therapy in the historical control group, in which P/F ratio decreased significantly after liberation from NIV and two patients received NIV rescue therapy after all. These results suggest that the weaning strategy from NIV through NHF application may be safe and effective in terms of that NHF could maintain sufficient oxygenation and prevent respiratory failure, which develops after liberation from NIV therapy.
In this study, P/F ratio, representing the oxygenation status, was maintained in the NHF therapy group after weaning from NIV, while oxygen face mask therapy could not maintain oxygenation level 
Conclusion
In this study, NHF with 50 l/min flow rate was found to have comparable 
